top
GLIOBLASTOMA NEWSLETTER
Volume 1, Number 4 - 8 September 2002	Volume 1 Archive

---

Dear Subscriber,

We have collected a series of references on the use in Clinical Trials of Temozolomide for Gliomas (excluding Metastases, Melanoma, Leukemia, etc.).

The source of material (62 Clinical Trial Reports):

1) All the abstracts (on the subject) from the medical database MEDLINE.
2) All the meeting abstracts (on the subject) from ASCO Meetings.
3) Some article abstracts not yet on MEDLINE.

All the references (with the original source text) are on the website: http://members.xoom.virgilio.it/glioblastoma/.

On the home page click on "Treatment" Section.
Then select the "Standard Chemotherapy" Temozolomide.
There are two page-links:

a) Temozolomide ASCO Trials
b) Temozolomide Clinical Trials.

On the link-page "Temozolomide Clinical Trials" the (25) references are so organized:

PHASE III CLINICAL TRIALS
Recurrent and Progressive Tumors/Temozolomide Alone(1)

PHASE II CLINICAL TRIALS
Recurrent and Progressive Tumors/Temozolomide Alone(11)
Recurrent and Progressive Tumors/Temozolomide Plus One Treatment Agent(1)
Newly Diagnosed Tumors/Temozolomide Plus One Treatment Agent(1)

PHASE I CLINICAL TRIALS
Recurrent and Progressive Tumors/Temozolomide Alone(6)
Recurrent and Progressive Tumors/Temozolomide Plus One Treatment Agent(5)

On the link-page "Temozolomide ASCO Trials" the (37) references are so organized:

PHASE II CLINICAL TRIALS
Recurrent and Progressive Tumors/Temozolomide Alone(16)
Recurrent and Progressive Tumors/Temozolomide Plus One Treatment Agent(4)
Newly Diagnosed Tumors/Temozolomide Plus Three Treatment Agents(1)

PHASE I CLINICAL TRIALS
Recurrent and Progressive Tumors/Temozolomide Alone(6)
Recurrent and Progressive Tumors/Temozolomide Plus One Treatment Agent(6)
Newly Diagnosed Tumors/Temozolomide Plus One Treatment Agent(4)

With best regards,
Giovanni Camporeale, M.Sc.
Editor, Glioblastoma Database & Newsletter